Menu
Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave Medical aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which Shockwave Medical refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes.
5403 Betsy Ross Dr
Santa Clara, California 95054
Phone: 15102794262
shockwavemedical.com
Isaac Zacharias , President at ShockWave Medical (NASDAQ: SWAV ), reported a large insider sell on September 27, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Zacharias sold 4,000 shares of ShockWave Medical . The total transaction amounted to $768,480. ShockWave Medical shares are trading up 1.9% at $203.43 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily to make an investing decision, however an insider … Full story available on Benzinga.com
Insider Sell: Isaac Zacharias Sells 4,000 Shares of ShockWave Medical Inc
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. In the second quarter, the strategy underperformed the Russell 2000 Growth Index and returned 2.50% (net), and the index return was 7.05%. Consumer Staples, Health Care, Industrials, and Information […]
Director Frank Watkins Sells 3,000 Shares of ShockWave Medical Inc
SANTA CLARA, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV ), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that Nick West, MA, MD, FRCP, FESC, FACC, has joined the company in the role of Associate Chief Medical Officer. Dr. West will report to Keith Dawkins, MD, Chief Medical Officer, and will be based in Santa Clara, with plans to succeed Dr. Dawkins as CMO in mid-2024. "Dr. West brings to Shockwave a wealth of expertise in the interventional cardiology space," said Dr. Dawkins. "Having known Nick for many years, I am confident that his expertise will be highly influential in further developing Intravascular Lithotripsy (IVL) as the standard of care for calcium modification, and will also be a valued asset in the evaluation and development of novel transformational technologies to augment our portfolio in the years to come." Dr. West joins Shockwave from Abbott Vascular, where he served as Chief Medical Officer and Divisional Vice President of Global Medical Affairs for the past four years.
Shockwave Medical (SWAV) said on Monday that chief financial officer Dan Puckett will step down in the first-quarter of 2024. SWAV added that its board of directors had initiated…
Fred Alger Management, an investment management company, released its “Alger Small Cap Focus Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, the fund underperformed the Russell 2000 Growth Index. The Consumer Discretionary and Energy sectors contributed to the fund’s relative performance in the quarter, while […]
Artisan Partners, an investment management company, released its “Artisan Global Discovery Fund” second quarter 2023 investor letter. A copy of the same can be downloaded here. In the second quarter, its Investor Class fund APFDX returned 1.78%, Advisor Class fund APDDX posted a return of 1.78%, and Institutional Class fund APHDX returned 1.83%, compared to a […]
